Tiagabine use while Breastfeeding
Drugs containing Tiagabine: Gabitril
Tiagabine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs. Because there is no published experience with tiagabine during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
One mother successfully breastfed her infant while taking tiagabine 24 mg and then 20 mg daily.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
1. Neppe VM. Successful tiagabine monotherapy during pregnancy and lactation: clinical and serum data. Epilepsia. 2000;41 (Suppl 7):200-1. Abstract. DOI: doi:10.1111/j.1528-1157.2000.tb01727.x
CAS Registry Number
- GABA Agonists
- Neurotransmitter Uptake Inhibitors
- Neuroprotective Agents
LactMed Record Number
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Tiagabine use during Pregnancy
- Tiagabine Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy